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Hereditary abnorma,Hties of the, A. frac-
tion of human haemoglobin may be: 
(a) structural, in which a genetically 
determined change in the, amino acid 
composition and sequence of either the· 
a:phal or the de.\tal po.lypetidel chains, re-
sults in the production of a' haemoglobin 
A2 variant and (b) quantitative, in which 
chang.es in concentra,tion in the haemo-
globin A" fraction occur as a result of 
activaition or repression of the genes for 
either the alphal or the, delta chains or as 
a result of the replacement of the normal 
genes for e!ther of these chains, by 
structurally mutant genes. Becausel the 
beta and: delta chains of human: haemo-
g!obins are linked, al number of condi-
tions a,lso involving the beta chain genes 
(delta .. betal hybrid chain haemoglobins, 
hereditary persistence of foetal haemo-
globin, the beta thalassaemias) produce 
changes in haemoglobin A2 concent-
ration. 
Several non-hereditary states ha,ve been 
shown to produce quantitative' changes 
in the haemoglobin A z fraction. 
A,t least four types of haemoglobin mO'-
lecule, are known to' occur at various stages 
of de,velopmem in normal human subjects. 
These are: haemoglobin Al (the major adult 
haemoglobin, accounting for some 98% O'f 
the' total haemoglobin after the first year of 
extra-uterine, life), haemoglobin A2 (the mi-
nor adult haemoglobin, accounting for some 
2-3% of the, total haemaglobin within a, few 
months after birth), haemoglobin F (the ma-
jor foetal haemoglobin, produced in the 
foetus from about the tenth week of intra-
uterine life· till birth and of which traoes only 
occur afte'r the' neonatall period) and haema-
globin Gower-2 (the embryonal or 'primitive' 
haemoglobin produced up to' the, twelfth 
we,ek of gestation). All these haemoglobin 
types are similar in that the'y have' a com-
mon tetrameric structure comprising two dif-
ferent pa,irs of polypeptide chains per mole-
cule" of which one palir is common to all 
forms (the alpha chain) and the second pair 
is characteristic o,f each form (and caHed be-
ta! chains in A 2 , gamma chalins, in F and ep-
silon chains in Gower-2). In addition tO'the 
above four haemoglobins, small amounts of 
haemoglobins containing only one type of 
chain also occur under normal conditions, 
thus, Gower-1 (containing four epsilon 
chains per molecule) occurs together with 
Gower-,2 during embryonal development, 
while haemoglobin Bart's (containing four 
gamma chains per mO'lecule) occurs in 
traces in many normal infants at birth. 
Abnorma,lities O'f haemoglobin A2 which 
a,ffect the structure of this haemoglobin frac-
tiO'n arise, on a. hereditary basis, whereas 
quantitative abnormalities affecting this frac-
tion ma1y be either hereditary or non-heredi-
tary. A brief summary of the available know-
ledge on the,se abnormalities will be present-
ed here. 
Normal haemoglobin A2 
Kunkel and Wallenius (1955) discover-
ed that electro-phoresis of haemoglobin 
solutions from normal persons on starch 
grains in an alkaline medium, revealls the 
existence, of a: second haemoglobin band 
(A 2 ) constituting 2-3% of the total pigment, 
in addition to' the major haemoglobin band 
(AI)' TOI these workers also is due the dis-
covery that the, haemoglobin A2 concentra,-
tion is almost doubled in patients with tha-
lassaemia minor. At birth, the A2 fr:action is 
present in trace amounts (0.2 - 0.3%) (Hor-
ton et at., 1962), but increases as the con-
centration. of haemoglobin F decrealses, so 
that adult le,vels are: reached within the first 
year of life. 
Detailed studies of purified haemoglobin 
A2 (by the techniques of peptide map analy-
sis, amino acid composition and sequence 
dete'rminaltion) have shown that each mole-
cule contains a pair of alpha polypeptide 
chains and a pair of chains similar to" but 
not identical with, the beta chalins of hae-
moglobin Al' These specific chains (delta 
chains) differ from beta chains in 10 amino 
acid residues' out of the 146 that constitute 
ealch of these, two kinds of chains (Schroe-
der and Jones, 1965). Because of this mark-
ed similarity between normal deha and beta 
chains, Ingram (1963) has proposed that the 
delta chain gene ha1s e'volved from the be,ta 
cha,in gene and this suggestion has been 
supported by the finding of a haemoglobin 
A2-like component only in the blood of 
primates. Haemoglobin A2 has a higher af-
finity for oxygen than haemoglobin A ,(Me-
yering et at., 1960; Huisman, 1963), and the 
finding of the same property in haemoglobin 
variants containing abnormal delta cha,ins 
(e.g., haemoglobin N2 and haemoglobin Le-
pore) (Huisman, 1963) indicate that this 
property is rel,a,ted to the structure, of the 
delta chains. Evidence has been obtained 
that the genetic loci responsible' for synthe-
sis of the beta and delta chains are close,ly 
linked (Boyer et al., 1963). 
A change, in the structure, (i.e. inform-
ation content) of the: genes for the alpha or 
delta chain will result in structural variants 
of haemoglobin A 2. In the, heterozygous state 
for such a, mutant gene, the amount of nor-
mal haemoglobin A z produce.d will be appro-
ximately hallf that found in norma,1 pe'rsons, 
while in the homo,zygous state for such a 
mutant gene:, haemoglobin A2 will. be, absent. 
Thus, production of a structural variant of 
haemoglobin A z will automatically decrease 
the, concentration of structurally normal: A2 
synthesised. In the absence of such structur-
al mutant genes, the production of a,lphal or 
delta: chains ma,y bel increased or decrea,sed 
by activation or repression respectivery of 
1:ihe'se ge,nes and this may have a hereditary 
or a, non-hereditary basis. 
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The' most popular technique used in the 
study ofabnormaij,ties of the haemoglobin 
A2 fraction is electrophoresis, making use 
of starch grain slabs or starch gels, filter pa,-
per or cellulose acetate as a supporting me-
dium and either densitometric scanni'ng, or 
el,ution and spectro-photometry for quantit-
ative, determinations. 
Structural vari'ation in haemoglobin A'2 
( a) Alphal chain variants 
Since alpha chalins occur in the: four nor-
mal human haemoglobins, production of a 
variant of vhe allpha chain will give' rise not 
only to al variant of haemoglobin Ai but also 
to variants of haemoglobin A2 (beyond the 
neonatal, period), of haemoglobin F (alt 
birth) and of haemoglobin Gower-2 (during 
the embryonal period) SO that in the individ-
ual heterozygous for an alpha chain variant 
both normal and abnormal ha'emoglobins Ai' 
A z, F and Gower-2 will be produced. In an 
individual homozygous for an alpha, chain 
variant, only abnormal haemoglobins A l , A z, 
F and Gower-2 will be produced. No such in-
stance ha's yet been reported, presumably 
becausel the' production of abnormal haemo-
globins in the embryo has lethal results. In 
most alpha chalin variants that have been 
described, decrelased concentrations of hae-
moglobin A z have' been found. 
(b) Delta chain variants 
Four variants of the delta chain which 
contain single amino acid substitutions have 
been discovered. These' are: 
(1) haemoglobin N2 (or B2), charact-
erized as! 0 16 gly -7 arg (Ball et 
al., 1966; Jones et al., 1967); 
(2) haemoglobin A2 Sphakia, oh a-
racterized as 02 his -7 arg (Jones 
et, al., 1966); 
(3) haemoglobin A z Flatbush, cha-
racterized a,s 0 22 ala -7 glu 
(Jones et al., 1967), and 
(4) haemoglobin A z Babinga, oharact-
erized as 0 136 gly -7 asp (De 
Jongand Bernini, 1968). 
In addition, alt least two haemoglobin 
vadants which appear to be hybrids of beta 
and delta cha,ins (thel Lepore haemoglobins) 
are known. No variants ,in which a deletion 
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of genetic material from the delta chain gene 
has occurred have so far been described. 
(i) Ha,emog;obin A/2 
This is by far the' commonest of the del-
ta chain va'riants. The heterozygous state for 
this variant has been found in 2% of an 
American, negro population (Huisman, 
1969), and has only been reported sporadic-
a;lIy from Italy (Silvestroni et: ar, 1963L Tur-
ke'y (Aksoy and Erdem, 1966L Germany 
(Be,tke, 1966L and Venezuela (Arends, 
1963). A variant that is beLieved to be A' 2 has 
recently been found in 1.2% of some 6600 
North American Indian subjects in the pro-
vince, of Alberta (Canada) (Vella, 1969L 
though not in the same ethnic group in the 
province of Sa,skatchewan (Vella and Guzak, 
1968). Ten instances of 1:he same variant in 
subjects of English, Scottish or Eastern 
European origin ha,ve also been found during 
a study of some, 30,000 Canadians from the 
province' of Manitoba (Vella" 1969L though 
none was found in a similar study in Sas-
katchewan (Vella, 1967). 
In the heterozygouS state, haemoglobin 
A/2 occurs in the presence of approximately 
half the normal amount of A 2 , while, in the 
homozygous, state, there is complete: ab-
sence of haemoglobin A2 (Ceppellini, 1959; 
Huisman et al., 196'j). Thi,s variant has also 
been reported in association with ,8-thalas-
saemia when both the Ao and A'" fraotions 
were increased in amount) (Cepp~lIini, 1959; 
Huisman et al., 1961 L with haemoglobin 
Flatbush (Huisman a,nd Lee, 1965L with 
haemoglobin S(Huisman, 1969) and with 
haemoglobin C (Huisman, 1969). 
(ii) Haemoglobin A2 Sphakia 
-rhis variant wa's discovered in one fa-
mily during the, course of screening o,f a sma,J1 
population in Sphakia, an isolated mounta,in-
ous region in Southern Crete. It wa,s only 
found in the' heterozygous state and was as-
socia;ted with a reduced level of haemoglobin 
A2 • 
(iii) Haemoglobin A2 Flartbush 
This variant was discovered by Ranney 
et al., (1963) during the investigation of a 
Puerto Rican family with sickle cell anaemia. 
The same ha,emoglobin has also been found 
in two unrelated negro families (Huisman 
and Lee, 1965). The homozygous state has 
not yet been reported, though the' variant 
hasl been found in association wi1:h haemo-
globin A/2 (Huisman and Lee, 1965L and 
with haemoglobin S (Ranne'y et al., 1963). 
(iv) Haemoglobin A2 Babinga 
A detailed report on this variant is not 
yet ava'ilable. 
( c ) De~ta,..betal hybrid chain variants 
Not all the known ha,emoglobin variants 
am characterised by single aminO' acid sub-
stitutions. In the Lepore haemoglobins, 
Baglioni (1962) showed that the alpha 
chains were normal, but the non-alpha chains 
had 1Jhe N-termina,1 sequence of the, delta 
chain, the length of the de,l,ta-betal hybrid be.-
ing the same as that of the beta and delta 
chains. l' he' most I:ikely e'xplanation for the 
origin of these hybrid variants is a non-
homologous crossing-over between parts of 
the delta and beta cha,in genes, resulting in 
the, formation of unequal genetic products of 
which one' is a' delta-beta hybrid gene' which 
codes for a Lepore haemoglobin (Baglioni, 
',962). The known proximity of the structur-
a,l gene,s for the' be,ta and delta, chains sup-
ports this explanation. 
Haemoglobin Lepore (or Lepore Bos-
ton) was first described by Gerald and 
D'iamond (1958) in a'ssociation with a clinic-
al picture of tha,lassa,emia in a negro family. 
A number of haemoglobin va,riants. with pro-
perties similar to those of Lepore Boston, 
and associated with a clinica'l picture, of tha-
lassaemia, ha,ve since been described (Le-
pore Hollandia - Bamabas and Muller, 
196,2; Py:os, - Fessas et: al., 1962; Lepore 
Cyprus - Beaven et al., 1964; Lepore. Bronx 
- Ranne,y and Jacobs, 1964; Lepore' W,ash-
ir..gton and Lepore Augusta - Labie et ai., 
1966). There seem to be at least two, type's 
of haemoglobin Lepore differing from each 
other in the proportions of beta' and delta 
cha,in residues that occur in the non-alpha 
chains. In the' first type, the delta chain se-
quence contributes the, first 87 or so amino 
ac:d re.sidues (as occurs in the Boston, Au-
gusta, Washington, Bronx variants and pro-
bably also in Cyprus and PylosL while in the 
second group the' delta chain contributeS' on-
Iy the first 22 or so amino acid residues (as 
occurs in the' Hollandia variant), the rest of 
the chain being contributed by 1:he beta chain 
sequence. 
The level of haemoglobin A2 is usually 
decreased in het,erozygotes for al Lepore 
variant, while the A2 fraction is absent in ho-
mozygotes for a Lepore variant. Haemo-
globin Lepore variants have been, reported in 
combination with j]-thatlassaemi,a (Pearson 
et at., 1959), with haemoglobin S (Stoma-
toyannopoulos and Fessas, 1962), and with 
haemoglobin C(Ranne'y and Jacobs, 1964). 
Quantitative. changes in 
haemog:obin A2 leve!s 
Besides the reduction in the level of 
haemoglobin A2 which arises a's a result of 
the, production of structural variants of eiher 
alpha or delta chains, several genetically de-
termined conditions may e'ithe'r increase or 
decrease the leve" of haemoglobin A2 with-
out being associated wi,th structural changes 
in Gither of the polypeptide chains of this 
haemoglobin. Orj' primary importance are' tlhe 
thalassaemIas. 
The term "thalassaemia" refers to a 
number of haematologic phenotypes, each of 
which is caused by a genetically determined 
inhibition of synthesis of one of the p'oly-
peptide chains of the physiologic haemoglo-
bins that occur in man. The inhibition of 
synthesis of a polypeptide chain may vary in 
expression from complete to partial. Since 
five different polypeptide, chains enter into 
the composition of the human haemoglobins, 
in theory, at least five types of thalassaemia, 
can be distinguished on the basis of which 
chain is primarily affected. A severe degree 
of inhibition of synthe'sis of either alpha or 
gamma or epsilon chains, arising on the' ba-
sis of homozygosity for the particular the-
la,ssaemial gene, because of the interference 
with production of embryonal and foetal hae-
moglobins would be' lethal, produce death in 
utero ,and bel difficult to detect. Three of the 
five, possible forms of thalassaemia are well 
documented (alphae-, beta-and delta-thalas-
saemita,). There is very good evidence for the' 
existence of several, varieties of beta, thalas-
saemia and of at least two of alpha thalas-
saemia (Weatherall, 1965; Weail:herall, 
1967). 
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Ca) Alpha: thalassaemia 
This type of thalassaemia may be very 
difficult to de'tectespecially in the heterozy-
gous state and in individuals beyond 1:he ne-
onatal pe'riod. In: the immediate post-natal 
period, infants with this trait produce, abnor-
mal amounts of haemoglobin Bart's with, 
very often, no other distinct haematologioal 
changes. The ha,emoglobin Bart's usually di-
sappears completely within six months, but 
traces of it and of haemoglobin H may occyr 
in aldults, but the haemoglobin A2 le:vels are 
usually normal. 
In haemoglobin H disease, (also some-
times called "alpha thalassaemia inter-
media"), a more severe inhibition of a,lpha 
chain synthesis leads to a disbalance' be-
tween the, rela,tive amounts of alpha and 
non-alpha cha,ins produced, the, resulting ex-
cess of non-alpha chains leading to the pro-
duction of tetramers which contain only one 
type of chain (only beta chains in haemoglo-
bin H and only gamma chalinsin haemoglo-
bin Bart's). Small 'amounts of a haemoglobin 
containing only delta chains have been isol-
ated ,in this disease (Dance and Huehns, 
1962). Because thel haemoglobin A2 level is 
almost inv,ariably low in this disease, where-
as in alpha thalassaemia heterozygotes it is 
usually within normal limits, it has been sug-
gested that two different alpha thalassaemia 
gen9s may bel required to produce haemo-
globin H disease, one' causing almost tota,1 
suppression of alpha chain synthesis, the 
other being 'sile,n!' or not e,xpressed appre-
ciabl,y (Huehns, 1965). 
In homozygouS ,alpha, thalassaemia, the 
predominant: haemoglobin at birth is haemo-
globin Bart's, and haemoglobin, A2 is absent. 
The condition is incompatible with life and 
has only been found in still-born infants with 
the: clinica,l picture of erythroblastosis foeta-
lis (Lie-Injo, 1962). 
(b) Betal thalassaemia 
Since t,he: first observation of Kunkel, 
and Wal:lenius (1955) that the haemoglobin 
A2 fraction was raised ,in thalassaemia minor 
to two to three times the level in normal 
subjects, this finding has become the malin 
diagnostic feail:ure of the beta thalassaemia 
trait. The mechanism of the incre'ase in the 
haemoglobin A2 fraction in the presence of a 
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beta chain gene which is functioning subnor-
ma,lIy is not yet cle,ar. Since individuals 
doubly heterozygous for beta thalassaemia, 
and for haemoglobin; A'2 show increased le-
vels of both the normal and the abnormal 
haemoglobin A2 fractions, the beta, thalas-
saemia gene results inincre'ased activity of 
both the delta' chain loci. The amount of 
haemoglobin A2 in homozygous beta thalas-
saemia (Cooley's anaemia, thalassaemia ma-
jor) is very variable and an eleva;t,ed level is 
not always found. Several varieties of beta 
thalassaemia ha,ve been described on the 
basis of the haemoglobin pattern in presum-
ed heterozygotes, as follows: 
(I) Classical beta thalassaemia ("A2 
thalassaemia"). This is the commonest va-
riety and is cha!1acterized by high levels of 
haemoglobin A2 (3.5 - 7.0%), normal or 
near normal levels of haemoglobin F (1.5 -
6.5%) and the characteristic erythrocyte 
morphology of thalassaemia. 
(i<i) Be,la: thalassaemia with raised 
haemoglobins A2 and F. This variety is si-
mila'r to (i) but the haemoglobin F level 
tends to be higher (5 - 15%). 
(iii) Beta, thalassaemia with isolated 
raised haemoglobin A 2 • ,In this variety only 
the haemoglobin A2 ·Ievel, is raised, the' hae-
moglobin F concentration and erythrocyte 
morphology being norma:!. 
(iv) Beta, thalassaemi'a: with normal 
A z and raised haemoglobin F ("8 -13 thalas-
saemia", "F tha,lassaemia('). In this variety, 
the haemoglobin F lelvel ,is ra,ised (8 - 36%), 
tne erythrocyte morphology is abnormal, but 
the haemoglobin A2 is within normal limits. 
( v) Beta thalassaemia with normal 
haemog.lobins A2 and F. In this variety nor-
mal ha!emoglobins A z and F I!evels occur in 
the presence o,f an abnormal erythrocyte 
morpho,logy and the finding of Cl{ tha,lassae-
mia-like state in 'a close r:elartJive. 
( c ) Deltal tha,lassaemia 
Fessas and Stomatoyannopoulous 
(1962) reported on a Greek patient whose 
haemoglobin was completely de,ficient in A2 
fraction. A similar finding has been report-
ed in a white American patient (Thompson 
et: al., 1965 a). No other abnormaNty of 
haemoglobin pattern was found in e'ither of 
these patients ,and it was concluded that 
synthesis
' 
of delta, chains in them was com-
pletely inactive or ,inhibited. Absence or 
marked deficiency o·f haemoglobin A z is con-
s'idered to arise' from homozygosity fora 
deltal thalassaemi'a! gene. 
F!1aser et al., (1964) have found appro-
ximately ha,lf the normal concentrations of 
haemoglobin A2 in several Greek families and 
consider these subjects to be heterozygous 
for a de.lta thalassaemia gene. Reports are 
also available of a delta thalasssaemia gene 
in association with hereditary pers'istence of 
haemoglobin F C~hompson et al., 1965 b), 
with sicklel ce'lI anaemia and sickl'e, cell tmit 
(Thompson et al., 1966 a), with haemoglo-
bin 0 trait (Thompson et al., 1966 b), as 
well as with beta thalassaemia trait (Thom-
pson et al., 1966 b, Fmser et al., 1964). 
( d) Deltal-beta: hybrid chain thalassaemias 
The' Lepore haemoglobins appear to' be 
struatural hybrids of delta and beta poly-
peptide, chains and are associated wi,th a' cli-
nical and haemotological picture of thalas-
saemia. They are often considered as thalas-
saemia pheno,types (Motulsky, 1964) and 
ha,ve been re,ferred to abO've. 
(c') ~-je,J(id.taljy persistence 
of haemoglobin F 
This condition is characterized by per-
s;stence of high levels of haemoglobin F into 
adult life. Though high levels of haemoglobin 
F are usually associated with thalassaemia, 
and in particular with homozygous beta 
tha'lassaemia, hereditary persistence of hae-
moglobin F can be clearly distinguished from 
the thalassaemia syndromes. ~he anomaly 
app,ears to arise from failure' or inactivity of 
the beta: and del,ta chain genes, with result-
ing production of gamma chains and per-
si,stence of haemoglobin F into adulthood. 
The haemoglobin, F is homogeneuolsy dis-tri-
buted throughout the erythrocytes. In the 
hetreozygous form the anomaly is not alsso-
dated with any clinical or haematological ab-
normalities, though the haemoglobin A z le-
ve,ls are decreased. In the homozygous form 
the, haemoglobin A2 fraction is completely 
absent (Conloy et al., 1962). 
(f) Haemog:obin Zurich 
This is an interesting inherited haemo-
globinopathy, in which increased amounts of 
haemoglobin A z occur. The mechanism by 
which the A z level is raised ,is however 
probably different from that operating in the 
case o,f beta tha'lassaemia genes. 
Haemoglobin Zurich was discovered in 
two related patients who developed severe' 
haemolytic crises a,fte,r oral therapy with sul-
fonamides (Frick et: ar., 1962). The' variant 
was found in 15 members, over four gene-
rations of thi,s family. Dur,ing the haemolytic 
episoge most of the erythrocytes contained 
inclusion bodies, but these were absent out-
side the haemolytic episodes. Intra-erythro-
cytio inclusion bodies can be produced by a, 
variety o,f oxidizing agents in erythrocytes 
containing haemoglobin Zurich. 
A s,econd fami,ly whh this haemoglohi-
nopathy has been reported (Rieder e't al., 
1965), ,in which the, haemoglobin variant was 
associa,ted with raised concentraltions of 
haemoglobin A 2 • The authors have explained 
the abnormal leve,ls of A2 as arising from the 
preferential loss of the unstable haemoglobin 
Zurich after synthesis. 
(g) Non-heredi,tary conditions associa,ted 
with apnormal ha,emoglobin A2 levels 
Decre'(j',sed amounts of haemoglobin' A2 
have be,en' reported ,in erythroleuk'aemi1al 
(Aksoy and Erdem, 1967) and in severe' and 
long-,sta'nding iron deficiency anaemia, (Cher-
noff, 1964). 
Increased amounts of haemoglobin, A2 
have been reported in pernicious anaemia in 
relapse (Josephson et: al., 1958), hereditary 
spherocytosis (Hal1me,ling and Moquin, 
1967), acute and chronic Pl'alSmodium vivax 
mallaria (Arends, 1967), inl'ater stages of 
pregnancy (Okcuoglu, et: al., 1963; Okcuoglu, 
1965) and in recipients of foetal haemopoie-
tic tissue (Bridges eit al., 1961). 
R8lferences 
AKSOY, M. and ERDEM, S., Israel J. Med. Se., 2, 
3IO (I966). 
AKSOY, M. and ERDEM, S., Nature, 2I3, 522 (I967). 
ARE::-IDS, T., Sangre (Barcelona), 8, I (I963). 
ARE::-IDS, T., Nature, 2IS, I5I7 (I967). 
BAGLIONI, C., Proc. Natl. Acad. Sci., U. S., 48, 
I880 (I962). 
BALL, E. 'oV., MEYNELL, M. J., BEALE, D., KYNOCH, 
P., LEHMANN, H., and STRETTON, A. O. W., Na-
ture" 209, I2I7 (I966). 
BARNABAS, J. and MULLER, C. J., Nature, I94, 931 
(I962). 
123 
BEAVEN, G.H., STEVENS, B.L., ELLIS, M.J., WHITE, 
J.C., BERNSTOCK, L., MASTERS, P., and STAPLE-
TON, T., Brit. J. Haemat., IO, I (I964)' 
BETKE, K, Folia Haemat., 9, 2I7 (I964)' 
BOYER, S.H., RUCKNAGEL, D.L., 'oVEATHERALL, D.J., 
and "vVATSON-\VILLIAMS, E.J., Amer. J. Human 
Genet., IS, 438 (I963)· 
BRIDGES, J.M., NEILI;" D.\V. and LEHMANN, H., 
Brit. Med. J., I, I349 (I96I). 
CEPPELLINI, R., in Giba Foundation Sympos:um on 
Biochemistry of Human Genetics. (Eds: \Vol-
stenholme, B. E. W., and O'Connor, C. M.). J. 
& A. Churchill, London, p. I33, (I959)· 
CHERNOFF, A.I., Ann. N. Y. Acad. Se., II9, 557 
(1964). 
CONLEY, C.L., WEATHERALL, D.J., RICHARDSON, S. 
N,. SHEPHERD, M.K., and CHAR ACHE, C., Blood, 
2I, 26I (1963). 
DANCE, N., and HUEHNS, E.R., Biochem. Biophys. 
Res. Commun., 7, 444 (I962). 
DE JO::-lG, W.W.W., and BERN1N1, L.F., quoted by 
Perutz, M. F., and Lehmann, H., Nature, 219, 
902 (I968). 
FF:SSAS, P. and STOMATOYANNOPOULOS, G., Nature, 
I95, I2 15 (1962). 
FESSAS, P., STOMATOYANNOPOULOS, G. and KARA-
KLIS, A., Blood, 24, I (I962). 
FRASER, G.R., KITSOS, C., MOTULSKY, A.G., STO-
MATOYAN;o(OPOULOS, G., LouKoPouLos, D., FES-
SAS, P., KATTAN1S, C., DEF~RANAS, B., ZANNOS-
MARIOLEA, L. and CHOREMIS, t., Ann. N. Y. Acad. 
Sci., II9, 4I5 (I964)· 
FR1CK, P.G., HITZ1GJ \lV.H., and BETKE, K., Blood, 
20, 26I (1962). 
GER.\LD, P.S. and DIAMOND, L.K., Blood, I3, 835 
(1958). 
HARMELING, J. G. and MoguIN, R: B., Amer. J. 
Clin. Path., 47, 454 (I967)· 
HORTON, B., THoMPsoN, R.B., DozY, A., NECHT-
MAN, C., N1CHOLS, E. and HU1SMAN, T.H.J., 
Blood, 20, 302 (I962). 
HUEHNS, E.R., Postgrad. Med. J., 41, 718 (I965)· 
HUISMAN, T. H. J., in Advances in Clinical Che-
mistry, vol. 6, p. 23I. Academic Press, New 
York (I963). 
HUISMAN, T.H.J., in Biochemical Methods in Red 
Cell Genetics, (Ed., J. Y. Yunis). Academic Press, 
N. Y., p. 39I (1969)· 
HUISMAN, T. H. J. and LEE, R. C., Blood, 26, 677 
(I965)· 
HUISMAN, T. H. J., PUNT. K. and SCHAAD, J. D. G., 
Blood, I7. 747 (I96I). 
INGRAM, V. M., The haemoglobins in genetics and 
evolution. Columbia University Press, New York, 
p. I46, (I963). 
JONES, R. T:, BRIMHALL, B., HUEHNS, E. R. and 
BARN1COT, N. A., Science, ISI, I406 (I966). 
JONES, R. T., BR1MHALL, B., and HUISl\IAN, T. H. 
J., BioI. Chem., 242, 5I4I (I967). 
124 
JOSEPHSO~, A. M., MASRI, M. S., SINGER, L., DWOR-
KIN, D. and SINGER, K., Blood, I3, 543 (1958). 
KU~KEL, H. G. and WALLENIUS, G., Science, I22, 
288 (1955). 
LABIE, D., SCHROEDER, W. A. and HUISMAN, T. H. 
J., Bioch:m. Biophys. Acta, I27, 428 (1966). 
LEE, R. C. and HurSMAN, T. H. J., Amer. J. Hu-
man Genet., IS, 69 (1963). 
LIE-INJO LUAN ENG. Blood, 22, 581 (1962). 
MEVERING, C. A., ISRAELs, A. C. M., STEBENS, T., 
HUlSMAN, T. H. J., Clin. Chim. Acta,s, 206 
(1959). 
MOTULSKY, A.G., Symp. Quant. BioI. 29, 399 (1964). 
OKCUOGLU, A., Acta Med. Turcica, 2, 219 (1965). 
OKCUOGLU, A., MINNICH, V. and ANDERSON, M.E.H., 
Blood, 22, 807 (1963). 
PEARSON, H.A., GERALD, P.S. and DIAMOND, L.K,. 
J. Dis. Child., 97, 409 (1959)· 
RANNEY. H. M. BRADLEY, T. B. and CORD OVA, F. 
A., Nature, I97, 164 (1963). 
RAN~EY, H. M. and JACOBS, A. S., Nature, 204-, 163 
(1964). 
RIEDER, R. F., ZINKHAM, W. H. and HOLTZMAN, 
N. A., Amer. J. Med. 39, 4 (1965). 
SCHROEDER, \\T. A. and JONES, R. T., Fortschrifte 
Chem. Org. Naturstoffe, 22, II3 (1965). 
SILVESTRON1, E., B1ANCO, 1. and MAGAL1~1, S., Lan-
cet, 2, 1384 (1963). 
STOMATOYANNOPOULOS, G. and FESSAS, P., J. Lab. 
Clin. Med., 62, 193 (1962). 
THOMPSON, R.B., HAVETT, B., ARD, E., OD01\!, J. 
and BELL, W.N., Acta Haemat., 36, 412 (1966 a). 
THq~IPSON, R. B., OD01\!, J., ARD. E. and BELL, 
W. N., Acta Genet. I6, 340 (1966 b.). 
TH'OMPSON, R. B., OD01\!, J., ARD, E. and BELL, vV. 
N., Acta Haemat., 33, 186 (1965 a). 
THOMPSON, R. B., WARR1NGTON, P., ODOM, J. and 
:)3ELL, W. N., Acta Genet., IS, 190 (1965 b). 
VELLA, F., Clin. Biochem., I, II8 (1967). 
VELLA, F., (1969). Unpublished observations. 
VELLA, F., and GUZAK, P., CEn. Biochem., 2, 153 
1968). 
WEATHERALL, D. J., The Thalassaemia Syndromes. 
Blackwell Scientific Publications, Oxford, (1965). 
vVEATHERALL, D. J., in Progress in Medical Genetics, 
Vol. 5. p. 8. (A. G. Ste:nberg and A. G. Beam, 
Editors). Grune and Stratton, N. Y. (1967). 
NO~ICE 
This peri'odical is pu,bllshed biannually in June aJnd tn Decem'ber. 
Contributions for the June issue are to reach the Editor, at the Bacterfo:ogy 
Laboratory, St. Luke's Hospital, ,Malta, by the 1st. Mia'y. They must be 
typewritten, with double spacing. References should be given by the 
author's name and by the year 'af publication. Articles are, to consist of 
reports of original work or studies or of case histories. 
We are happy to thank our advertisers for' their appreciation of the 
value of this publication as a medium of reaching the medical and dental 
professions in Malta. 
